HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Wesch Selected Research

Diphosphates (Pyrophosphates)

1/2021Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands.
7/2015γδ T cell activation by bispecific antibodies.
3/2013Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Wesch Research Topics

Disease

42Neoplasms (Cancer)
01/2022 - 01/2003
11Adenocarcinoma
01/2020 - 12/2004
4Infections
01/2020 - 01/2003
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2018
3Carcinogenesis
12/2019 - 03/2015
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2015 - 03/2014
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 03/2018
2Inflammation (Inflammations)
12/2019 - 01/2003
2Leukemia
01/2019 - 01/2007
2Lymphoma (Lymphomas)
01/2019 - 01/2007
2Hypersensitivity (Allergy)
11/2016 - 06/2011
2Respiratory Insufficiency (Respiratory Failure)
06/2014 - 11/2012
2Lung Injury
06/2014 - 08/2012
2Acute Lung Injury
11/2012 - 08/2012
1Bites and Stings (Sting)
01/2022
1Obesity
05/2021
1Type 2 Diabetes Mellitus (MODY)
05/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017
1Glioblastoma (Glioblastoma Multiforme)
01/2017
1Glioma (Gliomas)
04/2016
1Neoplasm Metastasis (Metastasis)
03/2015
1Pneumonia (Pneumonitis)
06/2014
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2014

Drug/Important Bio-Agent (IBA)

13LigandsIBA
01/2022 - 01/2007
7AntigensIBA
01/2022 - 01/2014
7T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 01/2007
5CytokinesIBA
01/2022 - 07/2009
5Bispecific AntibodiesIBA
01/2020 - 01/2014
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 11/2016
3Carrier Proteins (Binding Protein)IBA
01/2022 - 04/2016
3Diphosphates (Pyrophosphates)IBA
01/2021 - 03/2013
3Neoplasm Antigens (Tumor Antigens)IBA
01/2020 - 03/2014
3DisintegrinsIBA
03/2018 - 10/2013
3Metalloproteases (Metalloproteinases)IBA
03/2018 - 10/2013
3Surface-Active Agents (Surfactants)IBA
06/2014 - 08/2012
3LipopolysaccharidesIBA
06/2014 - 01/2010
2human ERBB2 proteinIBA
01/2022 - 01/2018
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2021
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 11/2009
2PlatinumIBA
01/2020 - 03/2018
2Granzymes (Granzyme)IBA
01/2019 - 11/2009
2Monoclonal AntibodiesIBA
01/2018 - 07/2009
2Trastuzumab (Herceptin)FDA Link
01/2018 - 11/2016
2Surface Antigens (Surface Antigen)IBA
01/2018 - 03/2013
2NK Cell Lectin-Like Receptor Subfamily KIBA
01/2017 - 04/2016
2diphosphoric acid (pyrophosphoric acid)IBA
11/2016 - 01/2010
2micaIBA
04/2016 - 10/2013
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
07/2014 - 01/2014
2EnzymesIBA
10/2013 - 08/2012
2AcidsIBA
11/2012 - 08/2012
2CeramidesIBA
11/2012 - 08/2012
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2012 - 08/2012
2Proteins (Proteins, Gene)FDA Link
01/2007 - 04/2006
1AntibodiesIBA
01/2022
1InterferonsIBA
01/2022
1Biological ProductsIBA
01/2022
1Zoledronic Acid (Zometa)FDA Link
01/2022
1Blood Glucose (Blood Sugar)IBA
05/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Cetuximab (Erbitux)FDA Link
01/2021
1Fc Receptors (Fc Receptor)IBA
01/2021
1Natural Killer Cell ReceptorsIBA
01/2021
1Galectins (Galectin)IBA
11/2020
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2020
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020
1KynurenineIBA
01/2020
1resiquimodIBA
01/2020
1Galectin 3 (LGALS3)IBA
01/2020
1ChitosanIBA
01/2020
1Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2019
1PerforinIBA
01/2019
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2019
1TNF-Related Apoptosis-Inducing LigandIBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
03/2018
1AmphiregulinIBA
03/2018
1Immunoglobulin Fab FragmentsIBA
01/2018
1pertuzumabIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
11/2017
1SteroidsIBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1Interleukin-9 (Interleukin 9)IBA
11/2016
1Temozolomide (Temodar)FDA LinkGeneric
04/2016
1Diphosphonates (Bisphosphonates)IBA
07/2015
1NitrogenIBA
07/2015
1Ligases (Synthetase)IBA
03/2015
1ProstaglandinsIBA
03/2015
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2015
1Secretory Phospholipases A2IBA
06/2014
1PhosphatidylglycerolsIBA
06/2014
11,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA
06/2014

Therapy/Procedure

20Immunotherapy
01/2022 - 12/2004
7Therapeutics
01/2022 - 12/2004
2Drug Therapy (Chemotherapy)
03/2018 - 01/2014
2Artificial Respiration (Mechanical Ventilation)
06/2014 - 11/2012
1Resistance Training
03/2018
1Adjuvant Chemotherapy
03/2018
1Chemoradiotherapy
01/2017